BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 28640095)

  • 1. Aldehyde dehydrogenase 1 expression is correlated with poor prognosis in breast cancer.
    Yao J; Jin Q; Wang XD; Zhu HJ; Ni QC
    Medicine (Baltimore); 2017 Jun; 96(25):e7171. PubMed ID: 28640095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde dehydrogenase 1 expression predicts poor prognosis in triple-negative breast cancer.
    Ohi Y; Umekita Y; Yoshioka T; Souda M; Rai Y; Sagara Y; Sagara Y; Sagara Y; Tanimoto A
    Histopathology; 2011 Oct; 59(4):776-80. PubMed ID: 22014057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of ALDH1 and TGFβ2 in benign and malignant breast tumors and their prognostic implications.
    Zheng R; Wang J; Wu Q; Wang Z; Ou Y; Ma L; Wang M; Wang J; Yang Y
    Int J Clin Exp Pathol; 2014; 7(7):4173-83. PubMed ID: 25120797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
    Wu S; Xue W; Huang X; Yu X; Luo M; Huang Y; Liu Y; Bi Z; Qiu X; Bai S
    Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OLC1 is overexpressed in breast cancer and its expression correlates with poor patient survival.
    Ou-Yang QH; Duan ZX; Jin Z; Lei JX
    Tumour Biol; 2014 Sep; 35(9):8823-7. PubMed ID: 24880589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.
    Morimoto K; Kim SJ; Tanei T; Shimazu K; Tanji Y; Taguchi T; Tamaki Y; Terada N; Noguchi S
    Cancer Sci; 2009 Jun; 100(6):1062-8. PubMed ID: 19385968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma.
    Liebscher CA; Prinzler J; Sinn BV; Budczies J; Denkert C; Noske A; Sehouli J; Braicu EI; Dietel M; Darb-Esfahani S
    Hum Pathol; 2013 Aug; 44(8):1465-71. PubMed ID: 23465277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ALDH1 Expression and Vasculogenic Mimicry Are Positively Associated with Poor Prognosis in Patients with Breast Cancer.
    Xing P; Dong H; Liu Q; Zhao T; Yao F; Xu Y; Chen B; Zheng X; Wu Y; Jin F; Li J
    Cell Physiol Biochem; 2018; 49(3):961-970. PubMed ID: 30184527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
    De Brot M; Rocha RM; Soares FA; Gobbi H
    Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldehyde dehydrogenase 1 (ALDH1) expression is an independent prognostic factor in triple negative breast cancer (TNBC).
    Ma F; Li H; Li Y; Ding X; Wang H; Fan Y; Lin C; Qian H; Xu B
    Medicine (Baltimore); 2017 Apr; 96(14):e6561. PubMed ID: 28383433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenase 1 expression in inflammatory breast cancer as measured by immunohistochemical staining.
    Gong Y; Wang J; Huo L; Wei W; Ueno NT; Woodward WA
    Clin Breast Cancer; 2014 Jun; 14(3):e81-8. PubMed ID: 24461456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in expression of the cancer stem cell marker aldehyde dehydrogenase 1 among estrogen receptor-positive/human epidermal growth factor receptor type 2-negative breast cancer cases with early, late, and no recurrence.
    Miyoshi Y; Shien T; Ogiya A; Ishida N; Yamazaki K; Horii R; Horimoto Y; Masuda N; Yasojima H; Inao T; Osako T; Takahashi M; Tomioka N; Endo Y; Hosoda M; Doihara H; Miyoshi S; Yamashita H;
    Breast Cancer Res; 2016 Jul; 18(1):73. PubMed ID: 27368476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
    Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
    Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer.
    Zhou L; Yu L; Zhu B; Wu S; Song W; Gong X; Wang D
    BMC Cancer; 2016 Nov; 16(1):876. PubMed ID: 27832750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALDH1 expression correlates with favorable prognosis in ovarian cancers.
    Chang B; Liu G; Xue F; Rosen DG; Xiao L; Wang X; Liu J
    Mod Pathol; 2009 Jun; 22(6):817-23. PubMed ID: 19329942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of aldehyde dehydrogenase 1 (ALDH1) in invasive breast carcinomas.
    Demir H; Dulgar O; Gulle BT; Turna H; Ilvan S
    Bosn J Basic Med Sci; 2018 Nov; 18(4):313-319. PubMed ID: 29924962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of aldehyde dehydrogenase 1 in invasive primary breast tumors and axillary lymph node metastases is associated with poor clinical prognosis.
    Dong Y; Bi LR; Xu N; Yang HM; Zhang HT; Ding Y; Shi AP; Fan ZM
    Pathol Res Pract; 2013 Sep; 209(9):555-61. PubMed ID: 23916993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of Aldehyde dehydrogenase 1 expression on prognosis for metastatic colon cancer.
    Fitzgerald TL; Rangan S; Dobbs L; Starr S; Sigounas G
    J Surg Res; 2014 Nov; 192(1):82-9. PubMed ID: 24953984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
    Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
    Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.